Form 4: Amarin Director Keith Horn Receives Stock Options and Restricted Stock Units

Director Keith Horn received stock options for 179,795 ordinary shares and 50,287 restricted stock units (RSUs) following Amarin's annual general meeting.

Summary

• Keith Horn, a director of Amarin Corporation, received stock options and restricted stock units (RSUs) on April 18, 2024.
• The stock options are for 179,795 ordinary shares at an exercise price of $0.87.
• These options vest over three years, with 33% vesting on the first anniversary and the remainder in equal quarterly installments.
• Horn also received 50,287 RSUs, which vest in three equal installments on April 18, 2025, April 18, 2026, and April 18, 2027.
• Each RSU represents a contingent right to receive one ordinary share or cash at Amarin's discretion.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to director compensation, which is neither particularly positive nor negative.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the options and RSUs.

Industry Context

Granting stock options and RSUs to directors is a common practice in the pharmaceutical industry to incentivize performance and align management's interests with those of shareholders. These grants are part of a broader compensation strategy to attract and retain talent.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice in the pharmaceutical industry for director compensation.
• Companies like Pfizer, Johnson & Johnson, and Novartis also use similar equity-based compensation plans to incentivize their directors and executives.
• The vesting schedules are typical, with vesting occurring over a three-year period to encourage long-term commitment.

Stakeholder Impact

• The grant of stock options and RSUs could potentially increase shareholder value if the director's performance leads to company growth.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates